medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2006, Number 2

<< Back Next >>

Rev Invest Clin 2006; 58 (2)

Age related spirometric changes in diabetic patients

Ortíz-Aguirre AR, Vargas MH, Torres-Cruz A, Quijano-Torres M

Language: Spanish
References: 43
Page: 109-118
PDF size: 121.51 Kb.


ABSTRACT

Background. Pulmonary volumes and expiratory flows progressively decline during aging, and some studies suggest that such decline is steeper among diabetic people Objective. To evaluate if diabetes mellitus (DM) accelerates the decline of pulmonary function occurring with aging. Methods. A spirometric study was carried out in type-2 DM outpatients attending the family physician office, as well as in a control group of nondiabetic subjects. Results. 144 type-2 DM patients (30-78 years old) and 139 nondiabetic subjects (31-78 years old) were studied. From all spirometric variables, only the forced vital capacity (FVC) and the forced expiratory volume at one second (FEV1) were significantly lower in diabetic patients (p ‹ 0.001). Multiple regression analysis corroborated that age and DM were associated with a lower pulmonary function, ruling out the influence of tobacco habit and body mass index. Nevertheless, the analysis of covariance showed that slopes of regression lines (age vs. spirometric variable) were not different between both groups. Conclusions. Diabetic patients had lower values of FVC and FEV1, as compared with nondiabetic subjects. However, the rate at which pulmonary function declined through age was similar in both groups.


REFERENCES

  1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20.

  2. Powers AC. Diabetes mellitus. In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL (Edi.). Harrison’s principles of internal medicine. 16a. ed. New York: McGraw-Hill; 2004, p. 2152-80.

  3. Paul RG, Bailey AJ. Glycation of collagen: the basis of its central role in late complications of ageing and diabetes. Int J Biochem Cell Biol 1996; 28: 1297-1310.

  4. Sandler M. Is the lung a “target organ” in diabetes mellitus? Arch Intern Med 1990; 150:1385-8.

  5. Chan E, Welsh C. Geriatric respiratory medicine. Chest 1998; 114: 1704-33.

  6. Schuyler MR, Niewoehner DE, Inkley SR, Kohn R. Abnormal lung elasticity in juvenile diabetes mellitus. Am Rev Respir Dis 1976; 113: 37-41.

  7. Schnapf BM, Banks RA, Silverstein JH, Rosenbloom AL, Chesrown SE. Pulmonary function in insulin-dependent diabetes mellitus with limited join mobility. Am Rev Respir Dis 1984; 130: 930-2.

  8. Primhak RA, Whincup G, Tsanakas JN, Milner RD. Reduced vital capacity in insulin-dependent diabetes. Diabetes 1987; 36: 324-36.

  9. Sandler M, Bunn AE, Stewart RI. Cross-section study of pulmonary function in patients with insulin-dependent diabetes mellitus. Am Rev Respir Dis 1987; 135: 223-9.

  10. Bell D, Collier A, Matthews DM, Cooksey EJ, McHardy GJ, Clarke BF. Are reduced lung volumes in IDDM due to defect in connective tissue? Diabetes 1988; 37: 829-31.

  11. Britton J. Is the carbon monoxide transfer factor diminished in the presence of diabetic retinopathy in patients with insulin-dependent diabetes mellitus? Eur Respir J 1988; 1: 403-5.

  12. Cooper BG, Taylor RG, Alberti MM, Gibson GJ. Lung function in patients with diabetes mellitus. Respir Med 1990; 84: 235-9.

  13. Innocenti F, Fabbri A, Anichini R, Tuci S, Pettina G, Vannucci F, De Giorgio LA, Seghieri G. Indications of reduced pulmonary function in type 1 (insulin-dependent) diabetes mellitus. Diabetes Res Clin Pract 1994; 25: 161-8.

  14. Barret-Connor E, Frette C. NIDDM, impaired glucose tolerance, and pulmonary function in older adults. The Rancho Bernardo Study. Diabetes Care 1996; 19: 1441-4.

  15. Lange P, Parner J, Schnohr P, Lensen G. Copenhagen city heart study: Longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults. Eur Respir J 2002; 20: 1406-12.

  16. Davis TM, Knuiman M, Kendall P, Vu H, Davis WA. Reduced pulmonary function and its associations in type 2 diabetes: the Fremantle diabetes study. Diabetes Res Clin Pract 2000; 50: 153-9.

  17. Marvisi M, Bartolini L, Del Borrello P, Brianti M, Marani G, Guariglia A, et al. Pulmonary function in non-insulin-dependent diabetes mellitus. Respiration 2001; 68: 268-72.

  18. Sherril DL, Lebowitz MD, Knudson RJ, Burrows B. Smoking and symptom effects on the curves of lung function growth and decline. Am Rev Respir Dis 1991; 144: 17-22.

  19. American Thoracic Society. Standardization of spirometry: 1987 update. Am Rev Respir Dis 1987; 136: 1286-96.

  20. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S: population. Am J Respir Crit Care Med 1999; 159: 179-87.

  21. Pérez-Padilla JR, Regalado-Pineda J, Vázquez-García JC. Reproducibilidad de espirometrías en trabajadores mexicanos y valores de referencia internacionales. Salud Pública Mex 2001; 43: 113-21.

  22. Lange P, Groth S, Kastrup J, Mortensen J, Appleyard M, Nybone J. Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study. Eur Respir J 1989; 2: 14-19.

  23. Lange P, Groth S, Mortesen S. Diabetes mellitus and ventilatory capacity: a five year follow up study. Eur Respir J 1990; 3: 288-92.

  24. Mori H, Okubo M, Okamura M, Yamane K, Kado S. Abnormalities of pulmonary function in patients with non-insulin-dependent diabetes mellitus. Intern Med 1992; 31: 189-93.

  25. Singh S, Sircar SS, Singh KP. Are ventilatory impairments related to early onset and long history of diabetes? J Indian Med Assoc 1995; 93: 458-9.

  26. Maiolo C, Mohamed EI, Di DN, Pepe M, Perriello G, De LA. Body composition and pulmonary function in obese type 2 diabetic women. Diabetes Nutr Metab 2002; 15: 20-5.

  27. Walter RE, Beiser A, Givelber RJ, O’Connor GT, Gottlieb DJ. Association between glycemic state and lung function in the Framingham Heart Study. Am J Respir Crit Care Med 2003; 167: 911-16.

  28. Davis WA, Knuiman M, Kendall P, Grange V, Timothy ME. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes. Diabetes Care 2004; 27: 752-7.

  29. Engstrom G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, Lindgarde F. Lung function and cardiovascular risk relationship with inflammation-sensitive plasma proteins. Circulation 2002; 106: 2555-61.

  30. Litonjua AA, Lazarus R, Sparrow D, DeMolles D, Weiss ST. Lung function in type 2 diabetes: the Normative Aging Study. Respir Med 2005; 99:1583-90.

  31. Fariña F, Furió V, Fernandez-Aceñero MJ. Nodular fibrosis of the lung in diabetes mellitus. Virchows Arch 1995; 427: 61-3.

  32. Weynand B, Jonckheere A, Frans A, Rahier J. Diabetes mellitus induces a thickening of the pulmonary basal lamina. Respiration 1999; 66: 14-19.

  33. Soulis L, Thallas V, Youssef S, Gilbert RE, McWilliam. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetología 1997; 40: 619-28.

  34. Villa MP, Cacciari E, Bernardi F, Cicognani A, Salardi S, Zapulla F. Bronchial reactivity in diabetic patients. Relationship to duration of diabetes and degree of glycemic control. Am J Dis Child 1988; 142: 726-9.

  35. Camilli AE, Burrows B, Knudson RJ, Lyle SK, Lebowitz MD. Longitudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation. Am Rev Respir Dis 1987; 135: 794-9.

  36. Tager IB, Segal M, Speizer FE, Weiss ST. The natural history of forced expiratory volume. Am Rev Respir Dis 1988; 138: 837-49.

  37. Xu X, Dockery DW, Ware JH, Speizer FE, Ferris BG Jr. Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment. Am Rev Respir Dis 1992; 148: 1345-8.

  38. Sherrill DL, Holberg CJ, Enright PL, Lebowitz MD, Burrows B. Longitudinal analysis of the effects of smoking onset and cessation on pulmonary function. Am J Respir Crit Care Med 1994; 149: 591-7.

  39. Sherrill DL, Enright P, Cline M, Burrows B, Lebowitz MD. Rates of decline in lung function among subjects who restart cigarettesmoking. Chest 1996; 109:1001-5.

  40. Canoy D, Luben R, Welch A, Bingham S, Wareham N, Day N, Khaw KT. Abdominal obesity and respiratory function in men and women in the EPIC-Norfolk Study, United Kingdom. Am J Epidemiol 2004; 159: 1140-9.

  41. Lazarus R, Sparrow D, Weiss T. Effects of obesity and fat distribution on ventilatory function. The Normative Aging Study. Chest 1997; 111: 891-8.

  42. Dirección General de Epidemiología. Encuesta Nacional de Adicciones. México: Secretaría de Salud; 1993.

  43. Olaiz G, Rojas R, Barquera S, Shamah T, Aguilar C, Cravioto P, López P, Hernández M, Tapia R, Sepúlveda J. Encuesta Nacional de Salud 2000. Tomo 2. La salud de los adultos. Cuernavaca, México: Instituto Nacional de Salud Pública; 2003.




2020     |     www.medigraphic.com